Adult attention deficit hyperactivity disorder
This article may require copy editing for grammar, style, cohesion, tone, or spelling. (December 2023) |
Adult Attention Deficit Hyperactivity Disorder | |
---|---|
Other names | Adult ADHD, adult with ADHD, ADHD in adults, AADD |
Specialty | Psychiatry, Clinical psychology |
Adult Attention Deficit Hyperactivity Disorder is the persistence of
This new insight on ADHD is further reflected in the DSM-5, which lists ADHD as a “lifespan neurodevelopmental condition,” and has distinct requirements for children and adults. Per DSM-5 criteria, children must display “six or more symptoms in either the inattentive or hyperactive-impulsive domain, or both” for the diagnosis of ADHD.[3] Older adolescents and adults (age 17 and older) need to demonstrate at least five symptoms before the age of 12 in either domain to meet diagnostic criteria.[3][6] The International Classification of Diseases 11th Revision (ICD-11) also updated its diagnostic criteria to better align with the new DSM-5 criteria, but in a change from the DSM-5 and the ICD-10, while it lists the key characteristics of ADHD, the ICD-11 does not specify an age of onset, the required number of symptoms that should be exhibited, or duration of symptoms.[6]
A final update to the DSM-5 from the DSM-IV is a revision in the way it classifies ADHD by symptoms, exchanging "subtypes" for "presentations" to better represent the fluidity of ADHD features displayed by individuals as they age.[3][6]
Three presentations
- Predominantly Inattentive Presentation (ADHD-I)
- Predominantly Hyperactive-Impulsive Presentation (ADHD-HI)
- Combined Presentation (ADHD-C)
Symptom manifestation and severity of ADHD are highly diverse and vary among individuals.[9] Hyperactive symptoms, specifically, often decrease starting in adolescence.[10] Inattention is a more common presentation in adult ADHD, manifesting as difficulty starting and completing tasks, forgetfulness, difficulty focusing, disorganization, and persistent tardiness.[7][10]
ADHD can only be diagnosed by a licensed clinician.[11] Diagnosis is made clinically via a comprehensive, structured interview to obtain a full history of the individual's current and childhood symptoms and their negative impact on daily functioning. A complete medical history should also be obtained, as the rates of coexistent conditions (comorbidities) with ADHD are high.[6][12][13] Supplemental history obtained from people close to the individual in different settings (e.g., parents, siblings, partners, teachers, coworkers, and employers) can be helpful in confirming a diagnosis.[11]
ADHD is a highly genetically influenced condition, meaning it commonly runs in families.[3][6][7][14] Individuals with a first-degree relative with ADHD demonstrate a risk of ADHD 4-5 times higher than the general population rate and have prevalence rates of around 20%.[12] The rate of inheriting the disorder is estimated to be about 76% among children and adolescents and between 70 and 80% among adults.[7][12] The exact causes of ADHD are still not fully understood, but non-genetic biological risk factors (e.g., low birth weight, events during pregnancy) and environmental factors are also thought to play a role in the development of ADHD.[11][12][14]
Effective management of ADHD generally requires a combination of psychoeducation (teaching affected individuals about ADHD and its presentation and effects), behavioral interventions (e.g., cognitive behavioral therapy (CBT)), pharmacotherapy (treatment utilizing medication), and coaching for ADHD.[10][12] Psychostimulants, or simply stimulants, are considered the first-line medication for the treatment of ADHD. Particularly for adults, amphetamines (e.g., dexamphetamine) are considered the most effective medication.[8][10][12]
Classification
ADHD presentations
The Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) categorizes ADHD into three presentations:[3]
- Predominantly Inattentive Presentation (ADHD-I)
- Meets criteria for inattentive but not hyperactive-impulsive presentation
- Predominantly Hyperactive-Impulsive Presentation (ADHD-HI)
- Meets criteria for hyperactive-impulsive but not inattentive presentation
- Combined Presentation (ADHD-C)
- Meets criteria for both, inattentive and hyperactive-impulsive presentations
ADHD-I is the most common presentation among adults, with 45% of adults with ADHD meeting criteria for the predominantly inattentive presentation.[15] 34% of adults with ADHD meet criteria for the combined presentation (ADHD-C), and 21% of adults with ADHD meet criteria for the predominantly hyperactive-impulsive presentation (ADHD-HI).[15]
Diagnostic criteria
The DSM-5 lists 18 possible symptoms that a person may exhibit that would be consistent with a diagnosis of ADHD. There are nine inattentive symptoms and nine hyperactive-impulsive symptoms.[3][10] Older adolescents and adults (age 17 and older) only need to demonstrate five symptoms in either the inattentive or hyperactive-impulsive presentation to meet the criteria for diagnosis.[3][12][13] This differs from the required six symptoms in either presentation for children to meet diagnostic criteria.[12]
In accordance with the updates to the DSM-5, published in 2013, the other criteria necessary for a diagnosis of ADHD in adults are as follows:[3][13]
- Symptoms have been present for at least 6 consecutive months
- Symptoms do not match the individual's level of development
- Several symptoms onset before age 12 years
- Several symptoms manifest in two or more domains (e.g., home, school, work)
- Symptoms disrupt or diminish social, academic, and occupational performance
- Symptoms cannot be better explained by another psychiatric disorder
Signs and symptoms
ADHD is a
Individuals with ADHD exhibit deficiencies in
Whereas teachers and caregivers responsible for children are often attuned to the symptoms of ADHD, employers and others who interact with adults are less likely to regard such behaviors as a symptom. In part, this is because symptoms do change with
Symptoms of ADHD (see table below) can vary widely between individuals, and throughout the lifetime of an individual. As the
The difficulties generated by these deficiencies can range from moderate to extreme, resulting in the inability to effectively structure their lives, plan daily tasks, or think of and act accordingly even when aware of potential consequences. These can lead to poor performance in school and work and can be followed by
As problems accumulate, a negative self-view becomes established and a
Studies on adults with ADHD have shown that, more often than not, they experience self-stigma and depression in childhood, commonly resulting from feeling neglected and different from their peers.[23] These problems may play a role in the high levels of depression, substance abuse, and relationship problems that affect adults with ADHD later in life.[24]
Emotional dysregulation, or the inability to properly manage one's emotions, as demonstrated by low frustration tolerance, irritability, negative emotional outbursts, and emotional lability, has been found to be a key symptom of ADHD in all age groups. Unlike other symptoms of ADHD that tend to improve or decline with age, emotional dysregulation has been shown to be more persistent into adulthood.[25] Despite the increasing recognition among clinicians of emotion dysregulation as a prominent symptom of ADHD, especially among adults, it is not recognized in the DSM-5 as a core symptom of ADHD for diagnostic criteria.[25] However, the DSM-5 does include the symptoms of emotional dysregulation as "associated features" that can support the diagnosis of ADHD.[3]
Inattentive-type (ADHD-I) | Hyperactive/impulsive-type (ADHD-HI) |
---|---|
In children:
|
In children:
|
In adults:[21]
|
|
Diagnosis
Screening for ADHD in adults
ADHD can only be diagnosed by a licensed clinician, and the first step to do so is via screening with validated tools to screen for ADHD in adults.[10][11][12] The Adult ADHD Self Report Rating Scale (ASRS) is a validated screening tool recognized by the World Health Organization (WHO) with a sensitivity and specificity of 91.4% and 96.0%, respectively.[12] Screening can guide clinical decision-making toward the proper diagnostic and treatment methods, can prevent further negative outcomes, and can reduce medical costs that may result from underdiagnosis.[10][12] Individuals who should be screened for ADHD include any adult with a chronic history of behaviors consistent with inattention, hyperactivity, impulsivity, restlessness, and emotional instability that started in childhood or early adolescence.[12] Due to its high rates of heritability, adults with a first-degree relative with ADHD should also be screened.[7][12][14] Other high-risk groups that should be screened include adults with a history of chronic mental health disorders (including, but not limited to, anxiety, depression, bipolar disorder), due to the high rates of comorbidity; adults within the criminal justice system or with a history of behavioral issues; and adults with multiple physical diseases.[2][12]
Diagnosing ADHD in adults
If an individual screens positively for ADHD, diagnosis is made clinically through a thorough, systematic interview with the aim of obtaining a full history of the individual's current symptoms and how those symptoms have inhibited their performance in daily activities. A history of childhood symptoms must also be obtained.[6][11][12] Whenever possible, supplemental information should be obtained from sources close to the individual (e.g., parents, siblings, significant other, colleagues) about the individual's symptom presentation and impairments in different settings.[3][11] These additional informants can aid the clinician in diagnosing ADHD in an adult because adults might not accurately recall childhood symptoms. Additionally, they tend to inaccurately report current symptom severity and impairment, due either to poor self-awareness or the development of coping mechanisms throughout their lifetime to manage symptoms of undiagnosed ADHD.[2][12][13] In addition to determining current symptoms, the clinical interview to diagnose ADHD should also evaluate for coexisting medical and mental health disorders, as there can be significant overlap in symptoms of ADHD and other conditions.[10][11][12][13][28]
ADHD cannot be diagnosed via symptom rating scales, neuropsychological tests, or brain imaging alone. These tools can be used, however, to screen for or support a diagnosis of ADHD as well as to quantify the severity and functional impairment of symptoms.[11][13][28]
Screening tools
Diagnosis tools
- Diagnostic Interview for ADHD in Adults, third edition (DIVA-5)[13][29]
- ACE+ (semi-structured diagnostic interview to assess for ADHD in adults, >16 years)[12]
- Conners Adult ADHD Diagnostic Interview for DSM-IV (CAADID)[12][13]
- Adult ADHD Clinical Diagnostic Scale (ACDS v1.2)[13]
- Continuous Performance Tests (CPTs) (cognitive tests of attention and executive function)[30]
Barriers to diagnosis of ADHD in adults
Adults face many potential difficulties in obtaining a diagnosis of ADHD. The diagnosis is often missed in the clinical setting in adults as a result of insufficient knowledge among clinicians about ADHD in adults.[10][12] This lack of knowledge may cause some clinicians to not diagnose ADHD in adults because they are worried about misdiagnosing it, do not feel comfortable prescribing stimulants, or are worried about worsening patients' coexisting conditions.[10][12] Additionally, clinicians commonly overlook symptoms of ADHD and/or fail to consider it as a diagnosis in adults due to the overlap in symptoms with other psychiatric conditions, such as anxiety disorders, mood disorders, substance use disorders, and personality disorders.[8][10][31] The symptoms of these psychiatric disorders may mask the symptoms of ADHD and lead clinicians to consider these disorders over ADHD.[2] ADHD also has high rates of comorbidity with these disorders in adulthood, further leading clinicians to pursue evaluation for these disorders over ADHD.[10] Furthermore, the stigma surrounding ADHD causes many adults to forego seeking treatment altogether.[12]
Another barrier to diagnosis is faced by highly intelligent or high-functioning adults.[11][12] These individuals are more likely to develop compensatory skills earlier in life to overcome the symptoms of undiagnosed ADHD and adapt to their environments, which can suppress some of the more obvious symptoms or behaviors of ADHD. As a result, when they seek treatment as adults, they may not demonstrate the level of dysfunction that is more readily recognized in individuals with ADHD.[12]
Diagnosis of ADHD can also be delayed in adults due to a lack of universal consensus on diagnostic criteria for diagnosing ADHD in adults as well as poor adherence by primary care physicians and mental health providers to current recommendations.[2][4]
ADHD in adult males
The most common ADHD presentation in adulthood is predominantly inattentive (ADHD-I).
Males with ADHD, children, and adults exhibit higher rates of externalizing disorders or behaviors that manifest as aggressive, disruptive, rule-breaking behaviors, making them more likely to be referred for ADHD treatment. Adult males with ADHD are also more likely to display antisocial behaviors associated with antisocial personality disorder.[7] Adults with ADHD are more prone to reckless driving and more frequent and severe crashes, with some studies showing an increased frequency in adult males with ADHD compared to females.[7]
Other results of adult ADHD are higher reported incidences of traffic citations, missed workdays, and accidents.[32] According to Fritz in a 2016 study, adult men with ADHD may be able to focus better on mental tasks after completing some type of physical exertion.[32] This may help individuals who suffer from adult ADHD. Mood improvements were shown to be statistically significant for a short while, but quickly, the mood would return to pre-exertion levels.[32]
ADHD in adult females
Symptomatology
There is increasing evidence that females with ADHD have symptom manifestations different from the typical symptoms or behaviors observed in males. While males are more likely to display the commonly recognized disruptive behaviors of ADHD, especially in childhood, females typically display more subtle behaviors of hyperactivity-impulsivity and/or are more likely to fit the inattentive presentation, leading to delayed diagnosis in females.[9][14][7] Of note, despite the variation in symptom severity and presentation, ADHD-HI is the most common presentation in preschoolers for both sexes. Clinicians should be aware that just like males, females can also exhibit symptoms of inattention as well as hyperactivity-impulsivity.[7]
Impulsivity in females with ADHD often manifests as excessive talking, blurting out responses, interrupting others, and fidgeting.[14][7] In females with ADHD, inattention often manifests as susceptibility to distraction, disorganization, feeling overwhelmed, forgetfulness, absence of effort or motivation, and difficulty receiving constructive criticism in professional settings.[9][7] Females with ADHD also exhibit greater internalizing disorders (i.e., mood disorders) than males with ADHD.[14] Notable symptoms of ADHD specific to adult females include lower self-esteem which can lead to self-harm, greater difficulty in maintaining relationships, increased risk of anxiety and/or mood disorders.[9][14] Females, beginning in childhood, are also more likely to develop compensatory strategies that may ultimately mask some of the primary symptoms of ADHD, because of societal gender roles that pressure young women/girls to take up less space and not be disruptive.[14]
Prevalence
The most common ADHD presentation in adulthood is predominantly inattentive (ADHD-I).[15][7] ADHD-I is also the most common presentation for females in childhood, and the symptoms of inattention have been shown to persist into adulthood more than those of the hyperactive-impulsive presentation more commonly observed in boys. Consequently, females demonstrate a higher frequency of a "life-persistent" form of ADHD, which helps explain the narrowing male-to-female diagnostic ratio from childhood to adulthood.[14] Another possible explanation for the male-to-female diagnostic ratio seen in adulthood is that adult diagnosis relies more heavily on self-report than reports from parents or teachers. Adult females are more likely than adult males to report issues and seek treatment, leading to increasing diagnosis rates in adult females and closing the prevalence sex gap.[14][7]
Pathophysiology
Over the last 30 years, research into ADHD has greatly increased.[33] There is no single, unified theory that explains the cause of ADHD. Genetic factors are presumed important, and it has been suggested that environmental factors may affect how symptoms manifest.[19][34]
It is becoming increasingly accepted that individuals with ADHD have difficulty with "executive functioning.". In higher organisms, such as humans, these functions are thought to reside in the frontal lobes. They enable recall of tasks that need accomplishing, organization to accomplish these tasks, assessment of consequences of actions, prioritization of thoughts and actions, keeping track of time, awareness of interactions with surroundings, the ability to focus despite competing stimuli, and adaptation to changing situations.[35]
Several lines of research based on structural and/or functional imaging techniques, stimulant drugs, and psychological interventions have identified alterations in the
Treatment
As a first step, adults with ADHD should receive
Medications
Medications to help treat ADHD include
Stimulants
In the UK, clinical guidelines recommend that psychostimulants be used as a first-line treatment.[47] For people who cannot be treated with stimulants due to a substance use disorder or other contraindications, atomoxetine is the suggested first-line treatment in the UK. In Canada, clinical guidelines suggest that first-line treatment be methylphenidate or lisdexamfetamine.[45] Non-stimulant medications are generally second-line treatments in Canada.[27]
Non-stimulant medications
The non-stimulant
Viloxazine, another selective norepinephrine reuptake inhibitor, was FDA-approved to treat ADHD in children, adolescents, and adults.[50]
Psychotherapy
Psychotherapy, including behavioral therapy, can help an adult with ADHD monitor their own behaviour and provide skills for improving organization and efficiency in daily tasks.[26][53] Research has shown that, alongside medication, psychological interventions in adults can be effective in reducing symptomatic deficiencies.[54] Cognitive behavioral therapy in particular can provide benefits, especially alongside medication, in the treatment of adult ADHD.[55][40][34]
Epidemiology
While ADHD has traditionally been viewed as a childhood disorder that fades with age, growing research has shown that ADHD often persists from childhood into adulthood.[4] Approximately 40–60% of individuals diagnosed with ADHD in childhood continue to exhibit some symptoms of it in adulthood, while approximately 15% continue to meet full diagnostic criteria.[6][10][13] An umbrella review of worldwide childhood prevalence rates of ADHD, published in 2023, reported a combined prevalence of 8.0% in children globally.[56] This same review reported a global combined prevalence of ADHD of 10% in boys and 5% in girls.[56] While the male-to-female ratio of ADHD diagnoses in childhood is about 2.3:1 in children, it approaches 1.5:1 or lower in adulthood.[14][9] This is consistent with research revealing underdiagnosis of ADHD in females during childhood.[9]
Due to the age-dependent decrease in symptoms of ADHD, the prevalence among adults is lower than that in children.[6] A meta-analysis of the global prevalence of ADHD in adults, published in 2021, estimated a collective prevalence of persistent adult ADHD of 2.58% globally in 2020.[4] Persistent adult ADHD is defined as meeting diagnostic criteria for ADHD in adulthood with the additional requirement of a confirmed childhood diagnosis.[4] This rate was compared to symptomatic adult ADHD, defined as meeting symptomatic diagnostic criteria for ADHD in adulthood without the requirement of a childhood diagnosis, which had an estimated combined prevalence of 6.76% globally in 2020.[4] When assessing the prevalence of persistent adult ADHD by World Bank regions (high-income countries (HICs) vs. low- and middle-income countries (LMICs)), the prevalence of persistent adult ADHD is significantly lower in HICs than in LMICs, with rates of 3.25% and 8.00%, respectively.[4] Estimating the prevalence of persistent adult ADHD by age demonstrated decreasing prevalence with increasing age, which is consistent with other studies that have shown that ADHD symptoms tend to diminish with age.[4]
Age Group
(in years) |
Prevalence (%) |
---|---|
18-24 | 5.05 |
25-29 | 4.00 |
30-34 | 3.29 |
35-39 | 2.70 |
40-44 | 2.22 |
45-49 | 1.82 |
50-54 | 1.49 |
55-59 | 1.22 |
60+ | 0.77 |
Another meta-analysis, published in 2020, specifically examined the prevalence of ADHD in older adults, defined as 45 years and older.[57] It estimated prevalence in older adults based on three different assessment methods: research diagnosis (based on DSM-validated scales), clinical diagnosis (based on clinical interview meeting DSM or ICD criteria), and treatment.[57] The combined prevalence of ADHD in older adults by research diagnosis was estimated to be 2.18%, accordant with the age-dependent decline of ADHD.[57] The combined prevalence of ADHD in older adults by clinical diagnosis was estimated to be 0.23%. The discrepancy in prevalence between research diagnosis and clinical diagnosis might be explained by either a potential overestimate by ADHD-rating scales or underdiagnosis by clinicians.[57] Lastly, the prevalence of treatment for ADHD in older adults was estimated to be 0.09%, which was less than half of the prevalence of clinically diagnosed ADHD.[57]
History
Early work on disorders of attention was conducted by Alexander Crichton in 1798, who wrote about "mental restlessness.".[58] The underlying condition came to be recognized in the early 1900s by Sir George Still.[59][60] The efficacy of medications on symptoms was discovered during the 1930s, and research continued throughout the twentieth century. ADHD in adults began to be studied in the 1990s and research has increased as worldwide interest in the condition has grown.[61]
In the 1970s, researchers began to realize that the condition now known as ADHD did not always disappear in adolescence, as was once thought.
Society and culture
ADHD in adults, as with children, is recognized as an impairment that may constitute a disability under U.S. federal disability nondiscrimination laws, including such laws as the Rehabilitation Act of 1973 and the Americans With Disabilities Act (ADA, 2008 revision), if the disorder substantially limits one or more of an individual's major life activities. For adults whose ADHD does constitute a disability, workplaces have a duty to provide reasonable accommodations, and educational institutions have a duty to provide appropriate academic adjustments or modifications, to help the individual work more efficiently and productively.[64][65]
In a 2004 study, it was estimated that the yearly income discrepancy for adults with ADHD was $10,791 less per year than their high school graduate counterparts and $4,334 lower for college graduate counterparts. The study estimates a total loss in productivity in the United States of over US$77 billion.[66]
Controversy
ADHD controversies include concerns about its existence as a disorder, its causes, the methods by which ADHD is diagnosed and treated including the use of stimulant medications in children, possible overdiagnosis, misdiagnosis as ADHD leading to undertreatment of the real underlying disease, alleged hegemonic practices of the American Psychiatric Association and negative stereotypes of children diagnosed with ADHD. These controversies have surrounded the subject since at least the 1970s.[59][67]
References
- PMID 33549739.
- ^ S2CID 232297097.
- ^ ISBN 978-0-89042-554-1.
- ^ PMID 33692893.
- PMID 36608036.
- ^ PMID 31982036.
- ^ PMID 32787804.
- ^ S2CID 258488317.
- ^ PMID 36995125.
- ^ PMID 32740107.
- ^ PMID 33549739.
- ^ S2CID 53714228.
- ^ S2CID 225042979.
- ^ S2CID 235758060.
- ^ S2CID 21715583.
- ^ PMID 20963192.
- PMID 19280582.
- ISBN 978-0-19-180225-6.
- ^ PMID 20815868.
- ISBN 978-3-642-24611-1.
- ^ PMID 17666230.
- S2CID 45481868.
- PMID 25799297.
- ^ Derrer D (n.d.). "Conditions Similar to ADHD". WebMD. Retrieved 16 October 2015.
- ^ PMID 32164655.
- ^ a b "NIMH » Could I Have Attention-Deficit/Hyperactivity Disorder (ADHD)?". www.nimh.nih.gov. Retrieved 2019-11-20.
- ^ a b "Diagnosis of ADHD in Adults". CHADD. Retrieved 2019-11-20.
- ^ S2CID 247168878.
- ^ a b "DIVA Foundation - DIVA-5 - Use of DIVA-5". www.divacenter.eu. Retrieved 2023-11-17.
- S2CID 257895503.
- PMID 35397064.
- ^ PMID 26741120.
- ^ PMID 22279437.
- ^ PMID 21658285.
- ^ "Divided Attention - an overview". ScienceDirect. Retrieved 2021-10-02.
- S2CID 6512707.
- PMID 15845424.
- S2CID 25814844.
- S2CID 937794.
- ^ PMID 30453134.
- PMID 11087189.
- S2CID 33187299.
- PMID 33085721.
- S2CID 34871481.
- ^ a b "Canadian ADHD Practice Guidelines". CADDRA. Archived from the original on 2020-10-27. Retrieved 2020-10-24.
- ^ S2CID 5390805.
- S2CID 28503360.
- S2CID 23171429.
- S2CID 207300617.
- ^ "Qelbree- viloxazine hydrochloride capsule, extended-release". DailyMed.
- PMID 21955201.
- S2CID 5975939.
- ^ "NIMH » Attention-Deficit/Hyperactivity Disorder". www.nimh.nih.gov. Retrieved 2019-11-20.
- S2CID 25802733.
- PMID 20599129.
- ^ PMID 37495084.
- ^ PMID 32798966.
- S2CID 6101515.
- ^ PMID 21258430.
- ISBN 9781134052196.
- PMID 29670320.
- ISBN 978-0801885853.
- ^ Barkley RA, Murphy KR, Fischer M (2008). ADHD in adults : what the science says. Guilford Press.
- ^ ADA Division, Office of Legal Counsel (22 October 2002). "Enforcement Guidance: Reasonable Accommodation and Undue Hardship Under the Americans with Disabilities Act". The U.S. Equal Employment Opportunity Commission.
- ^ Office of Civil Rights (25 June 2012). "Questions and Answers on Disability Discrimination under Section 504 and Title II". U.S. Department of Education.
- ^ "Breaking News: The Social and Economic Impact of ADHD". American Medical Association. 7 September 2004. Archived from the original on 22 October 2004.
- PMID 18804015.
Further reading
- Anastopoulos AD, Shelton TL (31 May 2001). Assessing attention-deficit/hyperactivity disorder. Topics in Social Psychiatry. New York: Kluwer Academic/Plenum Publishers. OCLC 51784126.
- Bellamacina M (2019). "ADHD in Women: A Review of Educational and Psychological Outcomes Through Early Adulthood" (PDF). Prized Writing.
- Bjerrum MB, Pedersen PU, Larsen P (April 2017). "Living with symptoms of attention deficit hyperactivity disorder in adulthood: a systematic review of qualitative evidence". JBI Database of Systematic Reviews and Implementation Reports. 15 (4): 1080–1153. S2CID 35553368.
- Division of Human Development, National Center on Birth Defects and Developmental Disabilities (29 September 2014). "Attention-Deficit / Hyperactivity Disorder (ADHD): Symptoms and Diagnosis". Centers for Disease Control and Prevention.
- CDC (2019-10-08). "Treatment of ADHD". Centers for Disease Control and Prevention. Retrieved 2019-11-20.
- Curatolo P, D'Agati E, Moavero R (December 2010). "The neurobiological basis of ADHD". Italian Journal of Pediatrics. 36 (1): 79. PMID 21176172.
- de Graaf R, Kessler RC, Fayyad J, ten Have M, Alonso J, Angermeyer M, et al. (December 2008). "The prevalence and effects of adult attention-deficit/hyperactivity disorder (ADHD) on the performance of workers: results from the WHO World Mental Health Survey Initiative". Occupational and Environmental Medicine. 65 (12): 835–842. PMID 18505771.
- Faraone SV, Biederman J, Spencer T, Wilens T, Seidman LJ, Mick E, Doyle AE (July 2000). "Attention-deficit/hyperactivity disorder in adults: an overview". Biological Psychiatry. 48 (1): 9–20. S2CID 15987079.
- Faraone SV, Asherson P, Banaschewski T, Biederman J, Buitelaar JK, Ramos-Quiroga JA, et al. (August 2015). "Attention-deficit/hyperactivity disorder". Nature Reviews. Disease Primers. 1: 15020. S2CID 7171541.
- Fuller-Thomson E, Lewis DA, Agbeyaka SK (November 2016). "Attention-deficit/hyperactivity disorder casts a long shadow: findings from a population-based study of adult women with self-reported ADHD". Child. 42 (6): 918–927. PMID 27439337.
- Ginsberg Y, Quintero J, Anand E, Casillas M, Upadhyaya HP (2014). "Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature". The Primary Care Companion for CNS Disorders. 16 (3): PCC.13r01600. PMID 25317367.
- Hechtman L (8 February 2009). "ADHD in Adults". In Brown TE (ed.). ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults (1st ed.). Washington, DC: American Psychiatric Publishing. p. 87. OCLC 701833161.
- Rettew DC, Hudziak JJ (2009). "Genetics of ADHD". In Brown TE (ed.). ADHD Comorbidities: Handbook for ADHD Complications in Children and Adults (1st ed.). Washington, DC: American Psychiatric Publishing. p. 32. OCLC 244601824.
- Valera EM, Brown A, Biederman J, Faraone SV, Makris N, Monuteaux MC, et al. (January 2010). "Sex differences in the functional neuroanatomy of working memory in adults with ADHD". The American Journal of Psychiatry. 167 (1): 86–94. PMID 19884224.
External links
- "Publications About ADHD". National Institute for Mental Health. Rockville, Maryland. Archived from the original on 2017-01-18. Retrieved 2015-04-13.